Molnlycke Health Care provides healthcare facilities with a unique team approach that results in tailored, well-rounded glove solutions. This includes a full-line of powder-free, low-protein latex and non-latex glove styles to address all specialty needs. As reported in The Cochrane Review, the Biogel patented, puncture indication glove system (in either latex or non-latex) provides protection and an alert system for barrier breach which increases practitioner safety.(xiv)
Biogel gloves are manufactured by the only major surgical glove company with an exclusively powder-free surgical glove line, and are made from high-tech material that is bonded with a thin inner coating of acrylate terpolymer. The smooth inner surface allows Biogel gloves to be easily donned with damp or dry hands without the need for a powder lubricant.
About Molnlycke Health Care US, LLC
Molnlycke Health Care U.S., LLC, consists of two divisions -- Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.
i American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology (AAAAI). Joint Statement Concerning the Use of Powdered and Non-powdered Natural Rubber Latex Gloves, July 21, 1997.
ii Renz H, Gemsa D. Effects
Copyright©2008 PR Newswire.
All rights reserved